Hunan Hansen Pharmaceutical Co Ltd (002412.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE100000PK2

Price
7.96 CNY
Market cap
4.01 bn CNY
P/E (2025)
20.22
P/S (2025)
3.86
Dividend yield
3.77 %
Net margin
19.07 %
Return on equity (ROE)
8.32 %
Return on assets (ROA)
7.36 %

Hunan Hansen Pharmaceutical Co Ltd financials

Fiscal year20242025
Revenue1.00 bn CNY1.04 bn CNY
Gross profit754.20 m CNY803.62 m CNY
Operating income253.18 m CNY241.86 m CNY
EBIT255.62 m CNY240.27 m CNY
Net income220.24 m CNY198.12 m CNY
Diluted EPS – continuing operations0.44 CNY0.39 CNY

Full history since 2006, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Hunan Hansen Pharmaceutical Co Ltd

Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers medications for digestive, cardiovascular, cerebrovascular, and urological diseases, as well as for traumatology and diagnostic applications. It provides its products in various forms, including injections, mixtures, tablets, capsules, granules, syrups, decoctions, tinctures, and pills. Hunan Hansen Pharmaceutical Co., Ltd. was founded in 1998 and is based in Yiyang, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.